Sign In
Buy XRAY
$9.88
+0.240 (+2.49%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
12:00pm, Friday, 08'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors a
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Investors to Connect
10:00am, Friday, 08'th Nov 2024
NEW YORK CITY, NY / ACCESSWIRE / November 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
DENTSPLY SIRONA Inc. (XRAY) Q3 2024 Earnings Call Transcript
03:02pm, Thursday, 07'th Nov 2024
DENTSPLY SIRONA Inc. (XRAY) Q3 2024 Earnings Call Transcript
XRAY Q3 Earnings & Revenues Beat Estimates, 2024 Guidance Revised
12:15pm, Thursday, 07'th Nov 2024
DENTSPLY SIRONA's third-quarter results showcase strong top-line growth in the Essential Dental Solutions segment. However, the lowered outlook for fiscal 2024 is a cause of concern.
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand
11:30am, Thursday, 07'th Nov 2024
Dentsply Sirona Inc. XRAY shares are trading lower on Thursday.
Dentsply (XRAY) Reports Q3 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 07'th Nov 2024
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est
Bronstein, Gewirtz & Grossman, LLC Encourages DENTSPLY SIRONA Inc. (XRAY) Stockholders to Inquire about Securities Investigation
10:00am, Thursday, 07'th Nov 2024
NEW YORK CITY, NY / ACCESSWIRE / November 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
Dentsply International (XRAY) Q3 Earnings and Revenues Beat Estimates
08:20am, Thursday, 07'th Nov 2024
Dentsply International (XRAY) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.49 per share a year ago.
Dentsply Sirona Reports Third Quarter 2024 Results
06:00am, Thursday, 07'th Nov 2024
CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2024.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
12:00pm, Wednesday, 06'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors a
NEW YORK CITY, NY / ACCESSWIRE / November 6, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
NEW YORK CITY, NY / ACCESSWIRE / November 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?
08:56am, Tuesday, 05'th Nov 2024
XRAY's third-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
NEW YORK CITY, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Stockholders to Connect
10:00am, Sunday, 03'rd Nov 2024
NEW YORK CITY, NY / ACCESSWIRE / November 3, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Comp
